
CDXS
Healthcare · Biotechnology · $127.1M market cap
$1.16+0.20 (+21.1%)Nov 13, 4:04 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +9.1% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.09 | -0.08 | +11.1% |
| Aug 11, 2026 | After the close | -0.17 | -0.13 | +23.5% |
| May 7, 2026 | After the close | -0.10 | -0.10 | 0.0% |
| Feb 26, 2026 | Time not confirmed | -0.04 | 0.14 | +485.4% |
| Nov 6, 2025 | After the close | -0.13 | -0.22 | -69.2% |
| Aug 13, 2025 | After the close | -0.15 | -0.16 | -6.7% |
| May 14, 2025 | After the close | -0.21 | -0.25 | -19.0% |
| Feb 26, 2025 | After the close | -0.04 | -0.13 | -225.0% |
| Oct 31, 2024 | After the close | -0.21 | -0.29 | -38.1% |
| Aug 8, 2024 | After the close | -0.24 | -0.32 | -33.3% |
| May 2, 2024 | After the close | -0.14 | -0.16 | -14.3% |
| Feb 28, 2024 | After the close | -0.12 | -0.10 | +16.7% |
| Nov 2, 2023 | After the close | -0.26 |
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the…
| -0.31 |
| -19.2% |
| Aug 3, 2023 | After the close | -0.14 | -0.17 | -21.4% |
| May 4, 2023 | After the close | -0.25 | -0.34 | -36.0% |
| Feb 23, 2023 | After the close | -0.23 | -0.14 | +39.1% |
| Nov 3, 2022 | After the close | -0.16 | -0.15 | +6.3% |
| Aug 4, 2022 | After the close | -0.12 | -0.04 | +66.7% |
| May 5, 2022 | After the close | -0.15 | -0.13 | +13.3% |
| Feb 24, 2022 | After the close | -0.22 | -0.16 | +27.3% |
| Nov 4, 2021 | After the close | -0.05 | 0.03 | +160.0% |
| Aug 5, 2021 | After the close | -0.12 | -0.01 | +91.7% |
| May 6, 2021 | After the close | -0.18 | -0.09 | +50.0% |
| Feb 25, 2021 | After the close | -0.12 | -0.06 | +50.0% |
| Nov 5, 2020 | After the close | -0.05 | -0.06 | -20.0% |
| Aug 6, 2020 | After the close | -0.13 | -0.07 | +46.2% |
| May 7, 2020 | After the close | -0.15 | -0.13 | +13.3% |
| Feb 27, 2020 | After the close | 0.05 | 0.02 | -60.0% |
| Nov 5, 2019 | After the close | -0.05 | 0.04 | +180.0% |
| Aug 6, 2019 | After the close | -0.07 | -0.08 | -14.3% |
| May 6, 2019 | After the close | -0.08 | -0.05 | +37.5% |
| Feb 26, 2019 | After the close | -0.03 | -0.01 | +66.7% |
| Nov 8, 2018 | After the close | -0.03 | -0.04 | -33.3% |
| Aug 8, 2018 | After the close | -0.08 | -0.02 | +75.0% |
| May 10, 2018 | After the close | -0.08 | -0.05 | +37.5% |
| Mar 8, 2018 | After the close | 0.05 | 0.02 | -60.0% |